A correlation between high prolactin and migraine was recently described in which administration of the dopamine D2 receptor antagonist cabergoline proved effective in reducing intense, unilateral face pain involved in prolactinoma-associated headache (76). The gene discussed is PRL; the disease is migraine disorder.